Developer docs
API playgroundTry for free, no card

Search company profiles

LifeSensors

Full company profile

uuid0006rsv

Namestring
LifeSensors
Legal namestring
LifeSensors Inc.
Websiteurl
lifesensors.com
Company typeenum
Private
Founded yearint
1996
Descriptiontext

LifeSensors Inc. is a privately held biotechnology company founded in 1996 and headquartered in Malvern, Pennsylvania, that develops and sells proprietary reagents, assay kits, and research services for ubiquitin proteasome system (UPS) research and targeted protein degradation drug discovery. The company's core technology is TUBEs (Tandem Ubiquitin Binding Entities), a proprietary reagent class that binds polyubiquitin chains with 1-10 nM affinity while protecting samples from deubiquitination and proteasomal degradation; the platform is augmented by patented UbiProbe 384-well TR-FRET and CHOP2 Reporter assay platforms for high-throughput deubiquitinase screening and by a complementary DUBTAC drug discovery offering. Its broader product catalog spans more than 60 enzyme products (E1, E2, and E3 ubiquitin enzymes), a deubiquitinase portfolio covering six DUB families, chain-selective and pan-selective TUBEs in multiple formats (magnetic beads, agarose, fluorescently labeled), ubiquitin chains and derivatives, antibodies, SUMO-based protein expression systems, PROTAC and molecular glue tools, and small molecule modulators.

The business operates a hybrid catalog-plus-services model. Catalog reagents and kits (TUBEs, enzymes, kits, plates, antibodies) are sold through a direct e-commerce storefront at lifesensors.com with publicly disclosed unit pricing ranging from approximately $55 for small molecule compounds to over $4,000 for complex enzyme kits, with authorized distributors handling institutional pricing for academic and government buyers. Fee-for-service offerings include PROTAC design and discovery, DUB screening and profiling, E3 ubiquitin ligase profiling, TUBE-based mass spectrometry proteomics, custom synthesis of PROTAC molecules and ubiquitin derivatives, and SUMO-fusion protein expression services. Customers are primarily pharmaceutical and biotechnology companies engaged in PROTAC, molecular glue, and DUBTAC drug discovery, supplemented by academic and government research institutions, contract research organizations, and neurodegeneration-focused researchers studying the PINK1/Parkin mitophagy pathway. Marketing and customer acquisition are driven primarily by scientific credibility (publications, conference presentations, press releases) and direct inside-sales engagement via phone and email, with social media presence on LinkedIn, X, and Instagram.

Capital structure remains private with no disclosed venture capital or private equity backing; the only disclosed funding event is a $5.53 million NIH grant awarded in 2023 to support PROTAC drug discovery and Alzheimer's disease diagnostic development. The company employs between 11 and 50 people, operates from a single Malvern headquarters, and is led by founder, President, and CEO Varsha Luthra. No revenue, headcount trend, M&A activity, or institutional investor participation is disclosed in available source material.

Short descriptiontext

LifeSensors Inc. is a private biotechnology company developing proprietary ubiquitin-binding reagents (TUBEs), assay kits, and research services for ubiquitin proteasome system research and targeted protein degradation drug discovery, serving pharmaceutical, biotech, academic, and CRO customers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMalvern, United States
HQ citystring
Malvern
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
ubiquitin proteasome reagents, protein degradation research, UPS assay kits, targeted protein degradation, biotech research tools
Industry1 code
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
NAICS code4 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Medical Laboratories621511
SIC code4 codes
  • Laboratory Analytical Instruments3826
  • Services-Testing Laboratories8734
  • Services-Commercial Physical & Biological Research8731
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Life Sciences Research Reagents
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Research Reagents
TypeOne Time License
Description

Sale of TUBEs, ubiquitin chains, DUB enzymes, E3 ligases, antibodies, and related research reagents for ubiquitin proteasome system research.

lifesensors.com
2Assay Kits and Plates
TypeOne Time License
Description

High-throughput screening kits including PROTAC assay plates, ubiquitin linkage ELISA kits, E3 ligase kits, and DUB profiling kits sold as catalog products.

lifesensors.com
3Custom Manufacturing
TypeOne Time License
Description

Custom synthesis and manufacturing services for PROTAC molecules, ubiquitin derivatives, and specialized research reagents.

lifesensors.com
4R&D Services
TypeProfessional Services
Description

Fee-for-service research including PROTAC design and discovery, DUB screening and profiling, mass spectrometry proteomics, and SUMO-fusion protein expression services.

lifesensors.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales
Pricing details8 tiers
1TUBE Products - Pan-Selective
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Pan-Selective TUBEs range from $92 (control beads) to $1,764 (TUBE 2 His6). Prices vary by tag format (GST, His6, Biotin, Agarose, Magnetic Beads) and capacity.

lifesensors.com
2K48 TUBEs HF
ModelUnit PricingBilling cadencePay-as-you-go
Notes

K48 TUBEs HF range from $557 (FLAG tag) to $1,993 (GST tag). High-affinity variants designed for proteasome-targeting chain detection.

lifesensors.com
3K63 TUBEs
ModelUnit PricingBilling cadencePay-as-you-go
Notes

K63 TUBEs range from $595 (Fluorescein/TAMRA) to $1,395 (Magnetic Beads). Designed for signaling and autophagy-related chain detection.

lifesensors.com
4PROTAC Assay Kits
ModelUnit PricingBilling cadencePay-as-you-go
Notes

PROTAC In Vitro Ubiquitination Assay Kit (PA770): $1,045. PROTAC Assay Plate Kit (PA950): $695. Linkage-specific ELISA kits: $1,475.

lifesensors.com
5E3 Ligase and DUB Kits
ModelUnit PricingBilling cadencePay-as-you-go
Notes

E3LITE Customizable Ubiquitin Ligase Kit (UC101): $1,214. E2 Selection Panel (UB200): $826. E1 Activity Assay Kit (UC105): $663.

lifesensors.com
6DUB Enzymes
ModelUnit PricingBilling cadencePay-as-you-go
Notes

DUB enzymes range from $130 (A20) to $4,277 (USP47). USP family enzymes range $152-$995. UCH family: $167-$318.

lifesensors.com
7E3 Ubiquitin Ligases
ModelUnit PricingBilling cadencePay-as-you-go
Notes

E3 ligases range from $419 (Cbl-b Core) to $1,292 (Cbl-b Full Length). Parkin variants: $602-$752.

lifesensors.com
8PROTAC Compounds
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Small molecule PROTAC tools range from $55 (Pomalidomide) to $633 (dBET1). VH compounds and Lenalidomide available from $60-$608.

lifesensors.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

LifeSensors develops and manufactures specialized research reagents, assay kits, and custom services for studying the ubiquitin proteasome system (UPS) and targeted protein degradation. Founded in 1996, the company supplies TUBEs (Tandem Ubiquitin Binding Entities) and related tools used by biotech, pharmaceutical, and academic researchers in drug discovery and proteomics workflows.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 1-10 nM binding affinity for polyubiquitin chains
+3 more records
Product overview1 text field

LifeSensors is a biotechnology company specializing in reagents, assays, and services for ubiquitin proteasome system (UPS) research and targeted protein degradation drug discovery. The product portfolio centers on TUBEs (Tandem Ubiquitin Binding Entities) as the core technology platform, complemented by comprehensive reagent lines including PROTAC/Molecular Glue tools, DUBTAC platforms, E1/E2/E3 ubiquitin enzymes (60+ products), Deubiquitinating Enzymes (DUBs) across 6 families (USP, UCH, OTU, JAMM, MJD, Viral/Bacterial), assay kits and plates (39+ products), antibodies, ubiquitin chains and derivatives, SUMO protein expression systems, and small molecule modulators. The company also offers extensive contract research services for DUB screening/profiling (UbiProbe TR-FRET, CHOP assays), E3 ligase profiling (15+ ligases, 50+ throughput), and mass spectrometry proteomics. Emerging technologies include LYTACs and BioPROTACs for alternative protein degradation approaches.

Product and service4 records
1TUBEs (Tandem Ubiquitin Binding Entities)
CategoryLife Sciences Research Reagents
2UPS Assay Kits
CategoryLife Sciences Research Reagents
3Targeted Protein Degradation Tools
CategoryDrug Discovery Reagents
4Custom R&D and Manufacturing Services
CategoryCustom Research Services
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Boston Biochem (Bio-Techne)
TypeDirect peer
Description

A pioneer in ubiquitin research reagents and assay kits, now part of Bio-Techne. Most directly comparable peer: sells ubiquitin chains, E1/E2/E3 enzymes, DUBs, and PROTAC-related tools serving the same UPS research customer base as LifeSensors.

TypeDirect peer
Description

Major antibody and reagents supplier with a deep ubiquitin/proteasome antibody and recombinant protein catalog. Comparable on product breadth in UPS reagents and target customer base of academic and pharma researchers.

TypeBroad incumbent
Description

Broad life science reagents catalog including ubiquitin pathway proteins, ELISA kits, and assay platforms. Larger, more diversified competitor with overlapping product categories but a much wider portfolio beyond UPS.

TypeBroad incumbent
Description

Established life science tools provider offering DUB and proteasome assays, TR-FRET detection chemistries, and custom manufacturing services. Comparable in offering HTS-grade biochemical assays and protein manufacturing for pharma and academic customers.

TypeDirect peer
Description

Supplies ubiquitin/proteasome pathway reagents, antibodies, and kits along with small molecule modulators. Closely comparable mid-sized competitor focused on UPS research and adjacent cell biology reagents.

TypeDirect peer
Description

Specialty company focused on ubiquitin pathway drug discovery, offering DUB and E3 ligase screening services and chemical biology tools. Directly comparable services-led competitor in the same niche.

TypeBroad incumbent
Description

Global antibody and reagent supplier with a large ubiquitin antibody portfolio and an expanding kits and recombinant proteins offering. Comparable customer base but a much larger and broader portfolio.

TypeDirect peer
Description

Catalog supplier of biochemical research reagents, including ubiquitin pathway tools and small molecule inhibitors. Comparable as a catalog-driven specialty reagent provider serving academic and pharma researchers.

TypeDirect peer
Description

Supplies small molecule tool compounds including E1/E2/E3 and DUB inhibitors, PROTAC tool compounds (e.g., dBET1, MZ1), and autophagy modulators. Direct overlap with LifeSensors' small molecule modulators catalog.

TypeDirect peer
Description

Specialty provider of ubiquitin-related drug discovery services and reagents, including DUB and E3 ligase screening assays. Direct comparable as a services-and-reagents player focused on the ubiquitin research and PROTAC space.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

LifeSensors

Life Sciences Research Reagentslifesensors.com

LifeSensors Inc. is a private biotechnology company developing proprietary ubiquitin-binding reagents (TUBEs), assay kits, and research services for ubiquitin proteasome system research and targeted protein degradation drug discovery, serving pharmaceutical, biotech, academic, and CRO customers.

What LifeSensors does

LifeSensors Inc. is a privately held biotechnology company founded in 1996 and headquartered in Malvern, Pennsylvania, that develops and sells proprietary reagents, assay kits, and research services for ubiquitin proteasome system (UPS) research and targeted protein degradation drug discovery. The company's core technology is TUBEs (Tandem Ubiquitin Binding Entities), a proprietary reagent class that binds polyubiquitin chains with 1-10 nM affinity while protecting samples from deubiquitination and proteasomal degradation; the platform is augmented by patented UbiProbe 384-well TR-FRET and CHOP2 Reporter assay platforms for high-throughput deubiquitinase screening and by a complementary DUBTAC drug discovery offering. Its broader product catalog spans more than 60 enzyme products (E1, E2, and E3 ubiquitin enzymes), a deubiquitinase portfolio covering six DUB families, chain-selective and pan-selective TUBEs in multiple formats (magnetic beads, agarose, fluorescently labeled), ubiquitin chains and derivatives, antibodies, SUMO-based protein expression systems, PROTAC and molecular glue tools, and small molecule modulators.

The business operates a hybrid catalog-plus-services model. Catalog reagents and kits (TUBEs, enzymes, kits, plates, antibodies) are sold through a direct e-commerce storefront at lifesensors.com with publicly disclosed unit pricing ranging from approximately $55 for small molecule compounds to over $4,000 for complex enzyme kits, with authorized distributors handling institutional pricing for academic and government buyers. Fee-for-service offerings include PROTAC design and discovery, DUB screening and profiling, E3 ubiquitin ligase profiling, TUBE-based mass spectrometry proteomics, custom synthesis of PROTAC molecules and ubiquitin derivatives, and SUMO-fusion protein expression services. Customers are primarily pharmaceutical and biotechnology companies engaged in PROTAC, molecular glue, and DUBTAC drug discovery, supplemented by academic and government research institutions, contract research organizations, and neurodegeneration-focused researchers studying the PINK1/Parkin mitophagy pathway. Marketing and customer acquisition are driven primarily by scientific credibility (publications, conference presentations, press releases) and direct inside-sales engagement via phone and email, with social media presence on LinkedIn, X, and Instagram.

Capital structure remains private with no disclosed venture capital or private equity backing; the only disclosed funding event is a $5.53 million NIH grant awarded in 2023 to support PROTAC drug discovery and Alzheimer's disease diagnostic development. The company employs between 11 and 50 people, operates from a single Malvern headquarters, and is led by founder, President, and CEO Varsha Luthra. No revenue, headcount trend, M&A activity, or institutional investor participation is disclosed in available source material.

LifeSensors firmographics

Firmographics
Name
LifeSensors
Legal name
LifeSensors Inc.
Website
https://lifesensors.com
Company type
Private
Founded year
1996
Operating status
Operating
Headcount range
11–50 employees
Short description
LifeSensors Inc. is a private biotechnology company developing proprietary ubiquitin-binding reagents (TUBEs), assay kits, and research services for ubiquitin proteasome system research and targeted protein degradation drug discovery, serving pharmaceutical, biotech, academic, and CRO customers.
Ownership category
akta.pro rank

LifeSensors industry classification

Industry
Product category
Life Sciences Research Reagents
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical Laboratories (621511)
SIC
Laboratory Analytical Instruments (3826), Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)

Keywords

  • Ubiquitin proteasome reagents
  • Protein degradation research
  • UPS assay kits
  • Targeted protein degradation
  • Biotech research tools

Where LifeSensors is headquartered

Location

Headquarters

HQ city
Malvern
HQ country
United States
HQ region
North America

Offices1 record

Markets served

LifeSensors business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales

Revenue model

  1. Research Reagents: Sale of TUBEs, ubiquitin chains, DUB enzymes, E3 ligases, antibodies, and related research reagents for ubiquitin proteasome system research.
  2. Assay Kits and Plates: High-throughput screening kits including PROTAC assay plates, ubiquitin linkage ELISA kits, E3 ligase kits, and DUB profiling kits sold as catalog products.
  3. Custom Manufacturing: Custom synthesis and manufacturing services for PROTAC molecules, ubiquitin derivatives, and specialized research reagents.
  4. R&D Services: Fee-for-service research including PROTAC design and discovery, DUB screening and profiling, mass spectrometry proteomics, and SUMO-fusion protein expression services.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goTUBE Products - Pan-Selective
Unit PricingPay-as-you-goK48 TUBEs HF
Unit PricingPay-as-you-goK63 TUBEs
Unit PricingPay-as-you-goPROTAC Assay Kits
Unit PricingPay-as-you-goE3 Ligase and DUB Kits
Unit PricingPay-as-you-goDUB Enzymes
Unit PricingPay-as-you-goE3 Ubiquitin Ligases
Unit PricingPay-as-you-goPROTAC Compounds

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

LifeSensors product offering

Product offering

Core offering

LifeSensors develops and manufactures specialized research reagents, assay kits, and custom services for studying the ubiquitin proteasome system (UPS) and targeted protein degradation. Founded in 1996, the company supplies TUBEs (Tandem Ubiquitin Binding Entities) and related tools used by biotech, pharmaceutical, and academic researchers in drug discovery and proteomics workflows.

Product overview

LifeSensors is a biotechnology company specializing in reagents, assays, and services for ubiquitin proteasome system (UPS) research and targeted protein degradation drug discovery. The product portfolio centers on TUBEs (Tandem Ubiquitin Binding Entities) as the core technology platform, complemented by comprehensive reagent lines including PROTAC/Molecular Glue tools, DUBTAC platforms, E1/E2/E3 ubiquitin enzymes (60+ products), Deubiquitinating Enzymes (DUBs) across 6 families (USP, UCH, OTU, JAMM, MJD, Viral/Bacterial), assay kits and plates (39+ products), antibodies, ubiquitin chains and derivatives, SUMO protein expression systems, and small molecule modulators. The company also offers extensive contract research services for DUB screening/profiling (UbiProbe TR-FRET, CHOP assays), E3 ligase profiling (15+ ligases, 50+ throughput), and mass spectrometry proteomics. Emerging technologies include LYTACs and BioPROTACs for alternative protein degradation approaches.

Differentiator

Problem solved

Functional benefit

Products and services

  • TUBEs (Tandem Ubiquitin Binding Entities)
  • UPS Assay Kits
  • Targeted Protein Degradation Tools
  • Custom R&D and Manufacturing Services

Quantifiable outcome

  • 1-10 nM binding affinity for polyubiquitin chains
  • +3 more outcomes

Companies that use LifeSensors

Customer profile

Segments4 records

Ideal customer profiles2 records

LifeSensors technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

LifeSensors partnerships and signals

Strategic signal

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

LifeSensors competitors and assessment

Company assessment

Direct peers

  • Boston Biochem (Bio-Techne): A pioneer in ubiquitin research reagents and assay kits, now part of Bio-Techne. Most directly comparable peer: sells ubiquitin chains, E1/E2/E3 enzymes, DUBs, and PROTAC-related tools serving the same UPS research customer base as LifeSensors.
  • Cell Signaling Technology (CST): Major antibody and reagents supplier with a deep ubiquitin/proteasome antibody and recombinant protein catalog. Comparable on product breadth in UPS reagents and target customer base of academic and pharma researchers.
  • Enzo Life Sciences: Supplies ubiquitin/proteasome pathway reagents, antibodies, and kits along with small molecule modulators. Closely comparable mid-sized competitor focused on UPS research and adjacent cell biology reagents.
  • Progenra: Specialty company focused on ubiquitin pathway drug discovery, offering DUB and E3 ligase screening services and chemical biology tools. Directly comparable services-led competitor in the same niche.
  • Cayman Chemical: Catalog supplier of biochemical research reagents, including ubiquitin pathway tools and small molecule inhibitors. Comparable as a catalog-driven specialty reagent provider serving academic and pharma researchers.
  • Tocris Bioscience (Bio-Techne): Supplies small molecule tool compounds including E1/E2/E3 and DUB inhibitors, PROTAC tool compounds (e.g., dBET1, MZ1), and autophagy modulators. Direct overlap with LifeSensors' small molecule modulators catalog.
  • Ubiquigent: Specialty provider of ubiquitin-related drug discovery services and reagents, including DUB and E3 ligase screening assays. Direct comparable as a services-and-reagents player focused on the ubiquitin research and PROTAC space.

Broad incumbents

  • R&D Systems (Bio-Techne): Broad life science reagents catalog including ubiquitin pathway proteins, ELISA kits, and assay platforms. Larger, more diversified competitor with overlapping product categories but a much wider portfolio beyond UPS.
  • Promega Corporation: Established life science tools provider offering DUB and proteasome assays, TR-FRET detection chemistries, and custom manufacturing services. Comparable in offering HTS-grade biochemical assays and protein manufacturing for pharma and academic customers.
  • Abcam: Global antibody and reagent supplier with a large ubiquitin antibody portfolio and an expanding kits and recombinant proteins offering. Comparable customer base but a much larger and broader portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

LifeSensors social profiles

Digital presence

LifeSensors financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LifeSensors leadership team

Management profile

Number of profiles

Profiles1 record

LifeSensors funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LifeSensors M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LifeSensors

What does LifeSensors do?

LifeSensors develops and manufactures specialized research reagents, assay kits, and custom services for studying the ubiquitin proteasome system (UPS) and targeted protein degradation. Founded in 1996, the company supplies TUBEs (Tandem Ubiquitin Binding Entities) and related tools used by biotech, pharmaceutical, and academic researchers in drug discovery and proteomics workflows.

Is LifeSensors a public or private company?

LifeSensors is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was LifeSensors founded?

LifeSensors was founded in 1996. It employs 11 to 50 people.

Where is LifeSensors based?

LifeSensors is headquartered in Malvern, United States, in the North America region.

How does LifeSensors make money?

Four revenue lines are on record. Research Reagents are the primary driver. The others are assay Kits and Plates, custom Manufacturing and R&D Services.

Who are LifeSensors's main competitors?

Direct peers on record are Boston Biochem (Bio-Techne), Cell Signaling Technology (CST), Enzo Life Sciences, Progenra, Cayman Chemical, Tocris Bioscience (Bio-Techne) and Ubiquigent. Broad incumbents are R&D Systems (Bio-Techne), Promega Corporation and Abcam.

Does LifeSensors have an API?

No public API is recorded for LifeSensors.

What industry is LifeSensors in?

LifeSensors's product category is Life Sciences Research Reagents. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comDifficult To Express Proteins Market Set for Rapid Expansion with High CAGR by 2024-2031 | Reaction Biology (Cobepa), LifeSensors Inc., Lucigen(LGC Group), BioLegend, Inc.(PerkinElmer Inc.)The global difficult-to-express proteins market is projected to grow from USD 4,007.6 million in 2022 to USD 9,052.1 million by 2031, a CAGR of 11.0%. Key players include Thermo Fisher, Merck, and BioLegend, with recent acquisitions such as Thermo Fisher's PeproTech purchase and Merck's Exelead acquisition.Zion Market ResearchBiosensors Market Size, Share, Trends and Forecast 2032The global biosensors market, valued at USD 28.68 billion in 2023, is projected to reach USD 60.26 billion by 2032, growing at a compound annual growth rate of 8.6%. This expansion is driven by increasing demand for accurate medical diagnostics, environmental monitoring, and advancements in point-of-care testing technologies. Key industry players identified in the report include Medtronic Inc., Abbott Point of Care Inc., LifeScan Inc., DuPont, and others.MemsworkInvestment Strategies in Emerging Biosensor Technologies (IA three-part study on biosensor investment strategies outlines the market's growth, drivers, and challenges, citing a projected rise from $31.01 billion in 2023 to $54 billion by 2028, an 11.8% CAGR. Wearables are expected to lead growth, with point-of-care testing reaching $29.8 billion by 2032. The authors note regulatory hurdles, scalability costs, and competition from Abbott, Roche and LifeSensors.openPR.comBioelectronics Market Is Booming Worldwide 2024-2031 | F. Hoffmann-La Roche Ltd, Abbott laboratories, LifeSensors, Siemens HealthcareThe bioelectronics market is experiencing significant growth due to the rising application of bioelectronics in healthcare, such as for implantable devices and glucose monitoring. This growth is further fueled by advancements in technology and a growing aging population, leading to increased demand for medical devices integrated with bioelectronics.